StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report released on Wednesday morning. The firm issued a buy rating on the stock.
Mannatech Price Performance
Mannatech stock opened at $8.20 on Wednesday. The stock’s 50-day moving average is $8.59 and its 200-day moving average is $8.77. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.51 and a current ratio of 1.07. Mannatech has a 12 month low of $7.50 and a 12 month high of $15.10.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its earnings results on Thursday, March 28th. The company reported ($0.94) EPS for the quarter. The company had revenue of $32.69 million for the quarter. Mannatech had a negative net margin of 1.70% and a negative return on equity of 19.19%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also
- Five stocks we like better than Mannatech
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Stocks Leading the U.S. Agriculture Comeback
- Stock Market Upgrades: What Are They?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Investing in the High PE Growth Stocks
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
